These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18174385)

  • 1. Mapping the structural requirements in the CB1 cannabinoid receptor transmembrane helix II for signal transduction.
    Kapur A; Samaniego P; Thakur GA; Makriyannis A; Abood ME
    J Pharmacol Exp Ther; 2008 Apr; 325(1):341-8. PubMed ID: 18174385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation studies of Ser7.39 and Ser2.60 in the human CB1 cannabinoid receptor: evidence for a serine-induced bend in CB1 transmembrane helix 7.
    Kapur A; Hurst DP; Fleischer D; Whitnell R; Thakur GA; Makriyannis A; Reggio PH; Abood ME
    Mol Pharmacol; 2007 Jun; 71(6):1512-24. PubMed ID: 17384224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insights into CB1 cannabinoid receptor signaling: a key interaction identified between the extracellular-3 loop and transmembrane helix 2.
    Marcu J; Shore DM; Kapur A; Trznadel M; Makriyannis A; Reggio PH; Abood ME
    J Pharmacol Exp Ther; 2013 May; 345(2):189-97. PubMed ID: 23426954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-7'-Isothiocyanato-11-hydroxy-1',1'-dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptor.
    Picone RP; Khanolkar AD; Xu W; Ayotte LA; Thakur GA; Hurst DP; Abood ME; Reggio PH; Fournier DJ; Makriyannis A
    Mol Pharmacol; 2005 Dec; 68(6):1623-35. PubMed ID: 16157695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): evidence for subtype specificity.
    Tao Q; McAllister SD; Andreassi J; Nowell KW; Cabral GA; Hurst DP; Bachtel K; Ekman MC; Reggio PH; Abood ME
    Mol Pharmacol; 1999 Mar; 55(3):605-13. PubMed ID: 10051546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist.
    Shen CP; Xiao JC; Armstrong H; Hagmann W; Fong TM
    Eur J Pharmacol; 2006 Feb; 531(1-3):41-6. PubMed ID: 16438957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.
    Gouldson P; Calandra B; Legoux P; Kernéis A; Rinaldi-Carmona M; Barth F; Le Fur G; Ferrara P; Shire D
    Eur J Pharmacol; 2000 Jul; 401(1):17-25. PubMed ID: 10915832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum.
    Wang X; Horswill JG; Whalley BJ; Stephens GJ
    Mol Pharmacol; 2011 Apr; 79(4):758-67. PubMed ID: 21189269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling.
    Tao Q; Abood ME
    J Pharmacol Exp Ther; 1998 May; 285(2):651-8. PubMed ID: 9580609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation.
    McAllister SD; Hurst DP; Barnett-Norris J; Lynch D; Reggio PH; Abood ME
    J Biol Chem; 2004 Nov; 279(46):48024-37. PubMed ID: 15326174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanisms.
    Anavi-Goffer S; Fleischer D; Hurst DP; Lynch DL; Barnett-Norris J; Shi S; Lewis DL; Mukhopadhyay S; Howlett AC; Reggio PH; Abood ME
    J Biol Chem; 2007 Aug; 282(34):25100-13. PubMed ID: 17595161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activation.
    Shim JY; Bertalovitz AC; Kendall DA
    J Biol Chem; 2011 Sep; 286(38):33422-35. PubMed ID: 21795705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?
    Kearn CS; Blake-Palmer K; Daniel E; Mackie K; Glass M
    Mol Pharmacol; 2005 May; 67(5):1697-704. PubMed ID: 15710746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors.
    Nebane NM; Kellie B; Song ZH
    FEBS Lett; 2006 Oct; 580(22):5392-8. PubMed ID: 16989818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual role of the second extracellular loop of the cannabinoid receptor 1: ligand binding and receptor localization.
    Ahn KH; Bertalovitz AC; Mierke DF; Kendall DA
    Mol Pharmacol; 2009 Oct; 76(4):833-42. PubMed ID: 19643997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered ligand dissociation rates in thyrotropin-releasing hormone receptors mutated in glutamine 105 of transmembrane helix III.
    del Camino D; Barros F; Pardo LA; de la Peña P
    Biochemistry; 1997 Mar; 36(11):3308-18. PubMed ID: 9116009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An aspartate residue at the extracellular boundary of TMII and an arginine residue in TMVII of the gastrin-releasing peptide receptor interact to facilitate heterotrimeric G protein coupling.
    Donohue PJ; Sainz E; Akeson M; Kroog GS; Mantey SA; Battey JF; Jensen RT; Northup JK
    Biochemistry; 1999 Jul; 38(29):9366-72. PubMed ID: 10413511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization.
    Rinaldi-Carmona M; Barth F; Congy C; Martinez S; Oustric D; Pério A; Poncelet M; Maruani J; Arnone M; Finance O; Soubrié P; Le Fur G
    J Pharmacol Exp Ther; 2004 Sep; 310(3):905-14. PubMed ID: 15131245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential coupling of the human cannabinoid receptors hCB1R and hCB2R to the G-protein G(alpha)i2beta1gamma2.
    Nickl K; Gardner EE; Geiger S; Heilmann J; Seifert R
    Neurosci Lett; 2008 Dec; 447(1):68-72. PubMed ID: 18845226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor.
    Oddi S; Dainese E; Fezza F; Lanuti M; Barcaroli D; De Laurenzi V; Centonze D; Maccarrone M
    J Neurochem; 2011 Mar; 116(5):858-65. PubMed ID: 21214565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.